跳至主要内容
临床试验/JPRN-UMIN000008066
JPRN-UMIN000008066已完成2 期

Efficacy of Rikkunshito on the Development and Progression of Cachexia in Gemcitabine-treated Pancreatic Cancer Patients – Randomized Phase II Study - Efficacy of Rikkunshito on the Development and Progression of Cachexia in Gemcitabine-treated Pancreatic Cancer Patients – Randomized Phase II Study

ational Cancer Center Research Insititute0 个研究点目标入组 40 人开始时间: 2012年5月31日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with cerebral metastases 2)Patients with peritoneal or pleural dissemination 3)Patients with ascites or pleural effusion 4)Patients with double cancer 5)Patients with interstitial pneumonia, lung fibrosis and severe pulmonary emphysema 6)Patinets with seizure disorder requiring anticonvulsants 7)Patients with disturbed consciousness 8)Patinets with gastrointestinal obstruction 9)Patients participating in other clinical trials 10)Patients with uncontrollable hypertension 11)Patients with diabetes mellitus treated with insulin, or uncontrollable diabetes mellitus 12)Patients with taking corticosteroid, androgen, progesterone or any other orexigenic medicine 13)Pregnant woman, Nursing woman, or woman not to agree with contraception 14)Pateints with infection requiring systemic treatment 15)Patiens having body temperature of >=38degrees at the enrollment 16)Patients with psychiatric disorder or any psychiatric symptoms, or considered in ineligible to the study.

研究者

发起方
ational Cancer Center Research Insititute

相似试验

Efficacy of Rikkunshito on the Development and... | 临床试验